Belle Wang Appointed Director of Operations at NFCR

About the role

Belle Wang has been appointed as the new Director of Operations at the National Foundation for Cancer Research (NFCR). With a strong background in operations, project planning, human resources, and financial management, Belle brings extensive experience in the biotech industry, including both research and leadership roles. She has coauthored multiple scientific publications and received recognition for her contributions to cancer research. Most recently, Belle served as Senior Vice President at Cellicure Inc., where she managed daily operations and supported strategic business development, contributing to the company's growth and operational efficiency.

Responsibilities

- Ensure the smooth and effective management of NFCR’s daily operations. - Support the leadership team in advancing the organization’s mission of advancing cancer research. - Collaborate with other departments to enhance operational efficiency and support strategic initiatives.

Qualifications

- Proven experience in operations, project planning, human resources, and financial management. - Extensive background in the biotech industry, including both research and leadership roles. - Strong track record of contributing to scientific advancements and organizational growth. - Leadership experience in managing teams and overseeing strategic business development.

Benefits

- Join a dynamic organization dedicated to advancing cancer research. - Opportunities to contribute to groundbreaking scientific discoveries. - A supportive and collaborative work environment.

Pay and Schedule

- Competitive salary commensurate with experience. - Flexible schedule to accommodate the demands of the role and personal life.

Schedule

- Full-time position with standard office hours.

Benefits

- Comprehensive health insurance coverage. - Retirement plan options. - Professional development opportunities. - Employee assistance program. Stay Informed Subscribe to OncoDaily Newsletter Don't miss the latest news in oncology: stay up to date with daily picks from OncoDaily. Subscribe